GeorgianaKEllisMD

Oncology • Seattle, WA

Associate Professor of Medicine, University Wash

Join to view full profile

Dr. Ellis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ellis' full profile

Already have an account?

Office
Seattle Cancer Care Alliance
825 Eastlake Avenue East
Seattle, WA 98109
Phone+1 206-288-7400

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1985 - 1988
University of WashingtonResidency, Internal Medicine, 1982 - 1985
University of Washington School of MedicineClass of 1982

Certifications & Licensure

WA State Medical License 1983 - 2017

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2008-2014
America's Top Doctors for Cancer Castle Connolly, 2007-2013

Clinical Trials

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer Start of enrollment: 2001 May 01
Completed
Phase 3
Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer Start of enrollment: 2002 May 01
Completed
Phase 2
Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12 Start of enrollment: 2001 Dec 01
Completed
Phase 2
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery Start of enrollment: 2003 Oct 01
Completed
Phase 2
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery Start of enrollment: 2006 May 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

7 citations
A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide P...
Lynn Symonds, Isaac C. Jenkins, Hannah M. Linden, Brenda F. Kurland, Julie Gralow
Clinical Breast Cancer. 2021-05-24
2 citations
Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab-paclitaxel for high-risk early-stage breast cancer.
Eunpi Cho, Qian Wu, Lena Rubinstein, Hannah M. Linden, Julie R. Gralow
The Breast Journal. 2018-03-13
150 citations
Antiemesis, version 2.2017 featured updates to the NCCN guidelines
Michael Berger, David S. Ettinger, Jonathan Aston, Sally Y. Barbour, Jason J Bergsbaken
Journal of the National Comprehensive Cancer Network. 2017-07-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member